Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)

NCT01860417 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease
Intervertebral Disc Disease
Low Back Pain

Interventions

BIOLOGICAL: Allogenic Mesenchymal Stromal Cells
DRUG: Mepivacaine

Sponsor

Red de Terapia Celular

Collaborators

[object Object]
[object Object]